Skip to content

The effect of ? syr in allergic rhinitis patients in the pilot study

The effect of ? syr on the gene expression levels of IL-4,IL-5, IL-10, IL-13, ?IL-17A ,and Interferon gamma in allergic rhinitis patients in the pilot study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20081024001391N4
Enrollment
20
Registered
2024-02-17
Start date
2024-01-30
Completion date
Unknown
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis. Allergic rhinitis due to pollen

Interventions

Intervention 1: Intervention group: Zofi Bell syrup is a combination of Nepeta bracteata extract, Adiantum capillus-venerisand Althaea officinalis, produced by Sanabel Daru Company, licensed by the F

Sponsors

Shahed University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Allergic rhinitis, both seasonal and permanent (intermittent and continuous) Having criteria for allergic rhinitis based on the ARIA form

Exclusion criteria

Exclusion criteria: The presence of chronic diseases such as asthma, diabetes, cancer, as well as trauma and recent nose surgery, and women who are pregnant and breastfeeding. Taking any chemical and herbal medicine known to be effective on allergic rhinitis lack of literacy

Design outcomes

Primary

MeasureTime frame
Gene expression levels of IL-5, IL-17A, interferon gamma, IL-4, IL-10, IL-13. Timepoint: The medicine will be taken for 4 weeks. Blood sampling will be at the beginning of the study and after the end of the medication in the fourth week. Method of measurement: with laboratory tests, respectively 1. Isolation of peripheral blood mononuclear cells (PBMCs); 2. Total RNA extraction; 3. cDNA synthesis; 4. Quantitative Real-Time PCR (qRT-PCR)Open in Google Translate•F.

Secondary

MeasureTime frame
Drug side effects. Timepoint: Second and fourth week. Method of measurement: Medication side effects questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Naseri

Shahed University

naseri@shahed.ac.ir+98 21 6646 4320

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026